HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- The importance of being accurate William N. Hait, MD, PhD
-
- Defining new prognostic markers in childhood acute lymphoblastic leukemia William L. Carroll, MD; Elizabeth A. Raetz, MD
- The future of drug development and the FDA’s Critical Path Initiative
- FDA approves bevacizumab and paclitaxel for first-line treatment of advanced NSCLC
- FDA approves new colorectal cancer drug
- After IMRT, almost 90% of men with prostate cancer were disease-free at eight years
- Childhood cancer treatment leads to complications later in life
- Eculizumab improves symptoms for patients with paroxysmal nocturnal hemoglobinuria
- Lenalidomide reduced transfusion burden in myelodysplastic syndrome
-
- Third-generation AIs improve survival among women with advanced breast cancer